Detalhe da pesquisa
1.
Metabolic syndrome is not associated to an increased risk of low bone mineral density in men at risk for osteoporosis.
J Endocrinol Invest
; 45(2): 309-315, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313972
2.
Metabolic syndrome is associated to an increased risk of low bone mineral density in free-living women with suspected osteoporosis.
J Endocrinol Invest
; 44(6): 1321-1326, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32960417
3.
Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction.
Int Braz J Urol
; 41(5): 967-74, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689523
4.
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and ß.
J Cell Physiol
; 226(5): 1334-9, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20945400
5.
[Antibacterial prophylaxis in endourological procedures]. / La profilassi antibatterica nelle manovre endourologiche.
Minerva Urol Nefrol
; 58(1): 73-80, 2006 Mar.
Artigo
em Italiano
| MEDLINE | ID: mdl-16760885
6.
Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement.
Prostate Cancer Prostatic Dis
; 8(1): 45-9, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15655566
7.
Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer.
J Clin Endocrinol Metab
; 82(8): 2566-9, 1997 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9253335
8.
Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells.
J Clin Endocrinol Metab
; 84(4): 1463-9, 1999 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10199796
9.
Estrogen receptor beta expression in human prostate tissue.
Mol Cell Endocrinol
; 178(1-2): 47-50, 2001 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-11403893
10.
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Clin Chim Acta
; 265(1): 65-76, 1997 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-9352130
11.
Surgical pathology examination of radical prostatectomy specimens. Updated protocol based on the Italian TAP study.
Anticancer Res
; 21(5): 3599-607, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11848530
12.
[Mepartricin in BPH. A new dosage approach]. / La mepartricina nella IPB. Nuovo approccio posologico.
Minerva Urol Nefrol
; 48(2): 117-20, 1996 Jun.
Artigo
em Italiano
| MEDLINE | ID: mdl-8815556
13.
[Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy]. / Valutazione in doppio cieco della mepartricina 150,000 U (40 mg) in confronto a placebo nella IPB.
Minerva Urol Nefrol
; 48(4): 207-11, 1996 Dec.
Artigo
em Italiano
| MEDLINE | ID: mdl-9005590
14.
[Mepartricin 150.000 (40 mg) vs mepartricin 50.000 U (13 mg) in the treatment of BIP. Double blind clinical trial]. / Mepartricina 150.000 U (40 mg) vs mepartricina 50.000 U (13 mg) nel trattamento della IPB. Ricerca clinica in doppio cieco.
Minerva Med
; 87(4): 147-54, 1996 Apr.
Artigo
em Italiano
| MEDLINE | ID: mdl-8700338
15.
Treatment of bilateral varicocele and other scrotal comorbidities using a single scrotal access: our experience on 34 patients.
Biomed Res Int
; 2014: 403603, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25140311
16.
Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction
Int. braz. j. urol
; 41(5): 967-974, Sept.-Oct. 2015. tab, graf
Artigo
em Inglês
| LILACS | ID: lil-767055
17.
[Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy]. / Validità terapeutica della mepartricina nella IPB: due anni di esperienza. Note preliminari sull'influenza della mepartricina su alcuni possibili fattori etiopatogenetici dell'IPB.
Minerva Urol Nefrol
; 40(2 Suppl): 16-7, 1988.
Artigo
em Italiano
| MEDLINE | ID: mdl-2460938
18.
[New prospective diagnostic serum markers in prostatic cancer]. / Nuove prospettive diagnostiche in tema di markers sierici nel carcinoma della prostata.
Minerva Med
; 77(13): 503-4, 1986 Mar 31.
Artigo
em Italiano
| MEDLINE | ID: mdl-2422605
19.
[The UroLink project: objectives and general data]. / Il progetto UroLink: obiettivi e dati generali.
Arch Ital Urol Androl
; 69(5 Suppl): 3-5, 1997.
Artigo
em Italiano
| MEDLINE | ID: mdl-9477620
20.
Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian Group.
Urol Int
; 60 Suppl 2: 11-7; discussion 35, 1998.
Artigo
em Inglês
| MEDLINE | ID: mdl-9607553